Immuno-chemo combo shows promise in shrinking early lung tumors before surgery
NCT ID NCT03366766
First seen Feb 24, 2026 · Last updated May 23, 2026 · Updated 10 times
Summary
This study tested whether giving nivolumab (an immunotherapy) along with chemotherapy before surgery could help shrink tumors in people with stage I to IIIA non-small cell lung cancer. The trial enrolled 14 patients whose cancer could be surgically removed. The goal was to see if the treatment could reduce the amount of viable tumor tissue, but the study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IIIA NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abington Hospital - Jefferson Health
Abington, Pennsylvania, 19001, United States
-
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.